Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 206NIH 84INDUSTRY 32NETWORK 27FED 3INDIV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Breast 2

Conditions

Ovarian Neoplasms 2Breast Neoplasms, Male 2Breast Neoplasms 2Endometrial Neoplasms 1

Interventions

Exercise 6pembrolizumab 5enzalutamide 4Docetaxel 4Colonoscopy 4Celecoxib 4sargramostim 3apalutamide 3Prednisone 3Methods 3Leuprolide 3Itraconazole 3Imiquimod 3Granulocyte-Macrophage Colony-Stimulating Factor 3Golytely 3Cryotherapy 3Abiraterone Acetate 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3abiraterone 2Yoga 2Topotecan 2Testosterone 2Tablets 2Simvastatin 2Radiosurgery 2Palliative Care 2Midazolam 2Gelatin 2Decision Support Techniques 2Collagenases 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
FED × sargramostim × Clear all
NCT01580696 2020-05-04

Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer

San Antonio Military Medical Center

Phase 1/2 Completed
51 enrolled
Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT00524277 2020-03-30

Vaccine Therapy in Treating Patients With Breast Cancer

San Antonio Military Medical Center

Phase 2 Completed
456 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02019524 2020-03-18

J65

San Antonio Military Medical Center

Phase 1 Completed
39 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡